Altshuler Shaham LTD Novo Cure LTD Transaction History

Altshuler Shaham LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $96,887 - $167,605	-743 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$124.11 - $190.17 $366,000 - $560,811	-2,949 Reduced 79.88%	743 $98,000
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $414,094 - $642,924	3,692 New	3,692 $639,000
Q1 2020 May 12, 2020	SELL	$57.05 - $95.75 $19,910 - $33,416	-349 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$68.3 - $93.8 $1,229 - $1,688	18 Added 5.44%	349 $29,000
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $8,969 - $14,181	145 Added 77.96%	331 $24,000
Q2 2019 Aug 06, 2019	SELL	$42.22 - $63.23 $8,697 - $13,025	-206 Reduced 52.55%	186 $12,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $12,528 - $21,999	392 New	392 $19,000
Q4 2018 Feb 11, 2019	SELL	$28.72 - $52.63 $4,451 - $8,157	-155 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.0 - $52.4 $4,960 - $8,122	155 New	155 $8,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.